EstroMend

En vente sur le marché américain (selon le DSLD)

Douglas Laboratories, food supplement from the US market

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

• Conditions légales

  Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.

  Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

• Official label: EstroMend
  Entered into DSLD on 23 July 2020. Retirée du marché américain le 22 March 2022 (selon le DSLD).

  • Different unit, without conversion : EstroMend A Phytocrine Proprietary Blend: quantity not stated in this version; 2,780 mg on the displayed label
  • Quantity stated differently, without estimation : Black Cohosh extract: 100 mg ; 50 mg in this version; 50 mg ; 100 mg on the displayed label

• Official label: EstroMend Hormone Specific Formulation
  Entered into DSLD on 25 July 2016. Retirée du marché américain le 16 September 2019 (selon le DSLD).

  • Active ingredient added : Proprietary Blend (1,390 mg ; 2,780 mg)
  • Active ingredient removed : EstroMend A Phytocrine Proprietary Blend (2,780 mg)
  • Active ingredient removed : EstroMend A Phytocrine Proprietary Blend (1,390 mg)
  • Same quantity, different name: Schizandra fruit extract in this version; Schisandra fruit extract on the displayed label (quantity not stated)
  • Quantity stated differently, without estimation : Black Cohosh extract: 100 mg ; 50 mg in this version; 50 mg ; 100 mg on the displayed label

• Official label: EstroMend Hormone Specific Formulation
  Entered into DSLD on 25 March 2014. Retirée du marché américain le 15 December 2015 (selon le DSLD).

  • Active ingredient added : Proprietary Blend (1,390 mg ; 2,780 mg)
  • Active ingredient removed : EstroMend A Phytocrine Proprietary Blend (2,780 mg)
  • Active ingredient removed : EstroMend A Phytocrine Proprietary Blend (1,390 mg)
  • Same quantity, different name: Schizandra fruit extract in this version; Schisandra fruit extract on the displayed label (quantity not stated)
  • Quantity stated differently, without estimation : Black Cohosh extract: 100 mg ; 50 mg in this version; 50 mg ; 100 mg on the displayed label

• Official label: Metabolic Lean
  Entered into DSLD on 25 March 2014. Retirée du marché américain le 15 December 2015 (selon le DSLD).

  • Active ingredient added : Capsaicinoids (0.5 mg)
  • Active ingredient added : Chromium (100 mcg)
  • Active ingredient added : Garcinia mangostana [fruit rind] extract (quantity not stated)
  • Active ingredient added : Meratrim Proprietary Blend (400 mg)
  • Active ingredient added : Sphaerantus indicus [flower heads] extract (quantity not stated)
  • Active ingredient removed : Bacopa extract (quantity not stated)
  • Active ingredient removed : Black Cohosh Extract (50 mg)
  • Active ingredient removed : Black Cohosh Extract (100 mg)
  • Active ingredient removed : Dong Quai root extract (quantity not stated)
  • Active ingredient removed : EstroMend A Phytocrine Proprietary Blend (2,780 mg)
  • Active ingredient removed : EstroMend A Phytocrine Proprietary Blend (1,390 mg)
  • Active ingredient removed : Gotu Kola extract (quantity not stated)
  • Active ingredient removed : Hops extract (quantity not stated)
  • Active ingredient removed : Pueraria root extract (quantity not stated)
  • Active ingredient removed : Red Clover extract (quantity not stated)
  • Active ingredient removed : Sage (quantity not stated)
  • Active ingredient removed : Schisandra fruit extract (quantity not stated)

Source

Official label

List declared on 22 September 2022 (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

Brand : Douglas Laboratories